Invicta Medical
Restera is a clinical-stage medical technology company dedicated to developing innovative treatments for sleep apnea. Their mission is to address the shortcomings of existing therapies, which are often expensive, intrusive, and have low patient compliance, by creating a first-of-its-kind neurostimulation system. Backed by significant funding and a team of experienced scientists, executives, and board members from top universities and medical institutions, Restera aims to revolutionize sleep apnea therapy and improve patient outcomes.
Industries
health-care
medical
therapeutics
Nr. of Employees
small (1-50)
Invicta Medical
Products
Intelligent implantable neurostimulation system for obstructive sleep apnea
A clinical-stage implantable neurostimulation system designed to provide minimally invasive stimulation of upper-airway nerves to treat obstructive sleep apnea; currently under clinical evaluation.
Intelligent implantable neurostimulation system for obstructive sleep apnea
A clinical-stage implantable neurostimulation system designed to provide minimally invasive stimulation of upper-airway nerves to treat obstructive sleep apnea; currently under clinical evaluation.
Expertise Areas
- Neuromodulation therapy development
- Clinical trial management for implantable devices
- Regulatory compliance for medical devices
- Implantable medical device systems engineering
Key Technologies
- Implantable neurostimulation
- Percutaneous hypoglossal nerve stimulation
- Ansa cervicalis stimulation
- Embedded firmware and system software